Karah Parschauer

Insider Reports History

Entity
Individual
Location
60 Leveroni Court, Novato, California
Signature
/s/ Karah Parschauer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karah Parschauer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Common Stock 58K $2.61M $45.00 Jun 12, 2024 Direct
Evolus, Inc. Director Common Stock 37.7K $495K $13.14 Feb 7, 2024 Direct
Ultragenyx Pharmaceutical Inc. EVP and Chief Legal Officer Stock Option (Right to Buy) 31.4K Mar 1, 2024 Direct
Anebulo Pharmaceuticals, Inc. Director Stock Option (right to buy) 30.4K Apr 21, 2022 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 29.5K Jun 9, 2023 Direct
Arcturus Therapeutics Holdings Inc. Director Stock Option (right to buy) 15K Jun 18, 2021 Direct
Evolus, Inc. Director Stock Option (Right to Buy) 9.38K Feb 7, 2024 Direct

Insider Reports Filed by Karah Parschauer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Jun 12, 2024 1 -$441K 4 Jun 12, 2024 EVP and Chief Legal Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 4 -$202K 4 Mar 5, 2024 EVP and Chief Legal Officer
EOLS Evolus, Inc. Feb 7, 2024 2 $0 4 Feb 9, 2024 Director
EOLS Evolus, Inc. Jan 30, 2024 1 -$157K 4 Feb 2, 2024 Director
TNYA Tenaya Therapeutics, Inc. Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. May 4, 2023 1 -$197K 4 May 5, 2023 EVP and Chief Legal Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 4 -$143K 4 Mar 3, 2023 EVP and Chief Legal Officer
EOLS Evolus, Inc. Jan 27, 2023 2 $0 4 Jan 31, 2023 Director
TNYA Tenaya Therapeutics, Inc. Sep 8, 2022 1 $0 4 Sep 9, 2022 Director
ANEB Anebulo Pharmaceuticals, Inc. Apr 21, 2022 1 $0 4 Oct 3, 2022 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 7, 2022 1 -$324K 4 Mar 8, 2022 EVP and Chief Legal Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$192K 4 Mar 3, 2022 EVP and Chief Legal Officer
EOLS Evolus, Inc. Jan 24, 2022 2 $0 4 Jan 26, 2022 Director
TNYA Tenaya Therapeutics, Inc. Dec 22, 2021 1 $0 4 Dec 23, 2021 Director
TNYA Tenaya Therapeutics, Inc. Dec 22, 2021 0 $0 3 Dec 23, 2021 Director
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$25.2K 4 Oct 18, 2021 EVP and General Counsel
RARE Ultragenyx Pharmaceutical Inc. Sep 8, 2021 3 -$339K 4 Sep 9, 2021 EVP and General Counsel
ARCT Arcturus Therapeutics Holdings Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 10, 2021 1 -$133K 4 Jun 11, 2021 EVP and General Counsel
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$35.6K 4 May 10, 2021 EVP and General Counsel